GM Advisory Group LLC Acquires 210 Shares of Veeva Systems Inc. (NYSE:VEEV)

GM Advisory Group LLC increased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 20.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,219 shares of the technology company’s stock after acquiring an additional 210 shares during the period. GM Advisory Group LLC’s holdings in Veeva Systems were worth $223,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Linscomb & Williams Inc. bought a new stake in Veeva Systems during the 4th quarter worth approximately $1,479,000. Robeco Institutional Asset Management B.V. grew its position in Veeva Systems by 32.7% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 206,220 shares of the technology company’s stock worth $365,000 after acquiring an additional 50,868 shares during the last quarter. APG Asset Management US Inc. bought a new position in Veeva Systems in the 4th quarter valued at $5,756,000. Quantum Capital Management LLC NJ boosted its position in Veeva Systems by 9.8% in the 4th quarter. Quantum Capital Management LLC NJ now owns 329,867 shares of the technology company’s stock valued at $63,506,000 after buying an additional 29,525 shares during the last quarter. Finally, Eisler Capital UK Ltd. bought a new position in Veeva Systems in the 4th quarter valued at $1,408,000. 88.20% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, SVP Jonathan Faddis sold 2,353 shares of the firm’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $200.00, for a total transaction of $470,600.00. Following the sale, the senior vice president now owns 9,035 shares of the company’s stock, valued at approximately $1,807,000. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 10.50% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of brokerages have commented on VEEV. UBS Group increased their price objective on Veeva Systems from $185.00 to $215.00 and gave the company a “neutral” rating in a research report on Monday, August 26th. Piper Sandler increased their price objective on Veeva Systems from $225.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Robert W. Baird increased their price objective on Veeva Systems from $245.00 to $251.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. JPMorgan Chase & Co. increased their price objective on Veeva Systems from $203.00 to $208.00 and gave the company a “neutral” rating in a research report on Monday, September 9th. Finally, Stifel Nicolaus decreased their price objective on Veeva Systems from $250.00 to $210.00 and set a “buy” rating on the stock in a research report on Friday, May 31st. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $229.96.

Veeva Systems Trading Up 0.2 %

Shares of Veeva Systems stock opened at $214.81 on Friday. The company has a market capitalization of $34.72 billion, a PE ratio of 63.37, a PEG ratio of 2.12 and a beta of 0.81. Veeva Systems Inc. has a 12 month low of $162.72 and a 12 month high of $236.90. The stock’s fifty day simple moving average is $199.25 and its 200 day simple moving average is $201.72.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.